The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end the ...

Members of the family who own OxyContin maker Purdue Pharma agreed to pay up to $7. ... though the family members themselves were not in bankruptcy. The new agreement protects family members ...

Members of the family who own OxyContin maker Purdue Pharma agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription painkiller, Connecticut Attorney ...

Purdue Pharma planned to exit bankruptcy last year under terms that gave the Sacklers a full release from all civil opioid claims even though they themselves were not declaring bankruptcy.

The proposal comes as Purdue Pharma is already considering bankruptcy, and is thought likely ... The settlement amount isn’t a cash deal, notes NBC. Part of it would comprise more than $4 ...

Purdue Pharma’s Sackler family owners are offering to increase their financial contribution to a bankruptcy settlement of opioid lawsuits while accepting some exposure to future litigation ...

MISSOULA, Mont. — NBC MT Today: Impact of grant, loan pause; Purdue Pharma settlement; record year at MSO ...

Purdue Pharma’s owners from the Sackler family ... reopening a path to end the longest and costliest corporate bankruptcy case stemming from the U.S. opioid crisis. The Sackler family members ...

which we look forward to presenting to the bankruptcy court,” Purdue Pharma said in a statement. Members of the Sackler family have been cast as villains and have seen their names removed from ...

Members of the family who own Connecticut-based OxyContin maker Purdue Pharma agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription painkiller ...